Partnership Opportunities
80+ drug developers from emerging biotechs and trailblazing established large pharmaceutical companies descended on Boston from December 10-12, 2024, to overcome some of the industry’s toughest challenges and bottlenecks.
We have spoken with the rare & genetic kidney disease drug development community, and they have highlighted their key pain points including data crunching from multi-omics and genetic testing, preclinical modelling of the kidney, leveraging health records for patient recruitment, baking patient-centric outcome measures and validated clinical biomarkers of response into trial design as they progress their preclinical and clinical pipelines towards approval.
Partner with us in 2025 to showcase your brand and capitalize on our audience of leading companies with active pipelines in rare and genetic kidney diseases.
HI-Bio, Otsuka, Purespring Therapeutics, Maze Therapeutics were amongst our 2023 attendees seeking partners to help them in the following areas:
Contract Clinical Research – Accelerate and support clinical R&D and position yourself as the leading clinical CRO in orphan kidney diseases with unique patient engagement strategies
Genetic Testing - Showcase your capabilities to advance molecular diagnostics and help identify patient subgroups to inform nephrologists on more personalized health care decisions for their patients
Novel Biomarkers – Communicate your capabilities to enhance the validation and accurate quantification of biomarkers of drug efficacy and disease progression
Preclinical Services – Elevate your expertise in preclinical models, tissue bioengineering capabilities and study tools for IgAN, FSGS, Alport Syndrome, PKD and other rare renal therapeutic areas
Why Partner in 2025?
Educate the Industry:
Secure a speaking position to explain how your solutions can directly support industry challenges in a room full of potential clients
Meet Senior Decision Makers:
Our meeting will unite CEOs, COOs, VPs, Directors, and Presidents creating a niche environment so you can network directly with the most senior decision makers in the industry
Showcase Your Products:
Bypass the crowds in large trade shows and assert your authority by displaying your services with our targeted exhibition space
Gain Brand Visibility:
Broaden your company’s exposure with 80+ dedicated delegates including Eli Lilly, Janssen, FDA, Novo Nordisk, Regulus Therapeutics, Travere Therapeutics and many more in attendance
Who Will You Meet?
*Statistics taken from the 3rd Rare & Genetic Kidney Disease Drug Development Summit
